Some of the most common include rheumatoid arthritis (attacking joint tissues), Hashimotos thyroiditis (affecting thyroid function), multiple sclerosis (targeting nerve myelin), psoriasis (affecting skin cells), inflammatory bowel diseases like Crohns and ulcerative colitis (involving digestive tract tissues), lupus (potentially affecting multiple organs), and type 1 diabetes (targeting insulin-producing pancreatic cells)
Anti-neuropathic pain activity of ajugarin-i via activation of Nrf2 signaling and inhibition of TRPV1/TRPM8 nociceptors in STZ-induced diabetic neuropathy
Greece Research on a protective protein in human stomach juice led to the discovery of BPC-157
The physiological is not limited to just bleaching the skin
Weight loss outcomes associated with semaglutide treatment for patients with overweight or obesity, JAMA Network Open (2022) Once-weekly semaglutide in adults with overweight or obesity, The New England Journal of Medicine (2021) Carnitine, National Institutes of Health (2023) Effects of three treatment modalities (diet, myoinositol, or myoinositol associated with D-chiro-inositol) on clinical and body composition outcomes in women with polycystic ovary syndrome, European Review for Medical and Pharmacological Sciences (2019) Who can perform semaglutide treatments?, American Med Spa Association (2023) Using fat-dissolving injections that are not FDA-approved can be harmful, U.S
